CDKN1A-mediated responsiveness ofMLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors-Reference-Cited by-同舟云学术

CDKN1A-mediated responsiveness ofMLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors

Published:2014-01-13 Issue:3 Volume:135 Page:751-762
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Chen Ya-Ping¹²³,Lin Hui-Ju⁴,Chen Jiann-Shiuh⁵,Tsai Ming-Ying⁶,Hsieh Hsing-Pang⁷,Chang Jang-Yang¹²⁸,Chen Nai-Feng⁹,Chang Kung-Chao¹⁰,Huang Wen-Tsung¹¹¹²,Su Wu-Chou¹²,Yang Shu-Ting⁹,Chang Wen-Chang¹³,Hung Liang-Yi⁹¹⁴¹⁵,Chen Tsai-Yun¹²³

Affiliation:

1. Division of Hematology/Oncology; National Cheng Kung University Hospital; Tainan Taiwan

2. Department of Internal Medicine; National Cheng Kung University Hospital; Tainan Taiwan

3. Graduate Institute of Clinical Medicine; National Cheng Kung University; Tainan Taiwan

4. Department of Pharmacology; National Cheng Kung University; Tainan Taiwan

5. Departments of Pediatrics; National Cheng Kung University Hospital; Tainan Taiwan

6. Eppley Institute for Research in Cancer and Allied Diseases; University of Nebraska Medical Center; Omaha NE

7. Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes; Zhunan Miaoli County Taiwan

8. National Institute of Cancer Research, National Health Research Institutes; Tainan Taiwan

9. Institute of Bioinformatics and Biosignal Transduction; National Cheng Kung University; Tainan Taiwan

10. Department of Pathology; National Cheng Kung University Hospital; Tainan Taiwan

11. Division of Hematology/Oncology, Chi-Mei Medical Centre; Liouying Tainan Taiwan

12. Department of Internal Medicine; Chi-Mei Medical Centre; Liouying Tainan Taiwan

13. Graduate Institute of Medical Science, College of Medicine; Taipei Medical University; Taipei Taiwan

14. Center for Infectious Disease and Signal Transduction Research; National Cheng Kung University; Tainan Taiwan

15. Institute for Cancer Biology and Drug Discovery, College of Medical Science and Technology; Taipei Medical University; Taipei Taiwan

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Biology, risk stratification, and therapy of pediatric acute leukemias: an update;Pui;J Clin Oncol,2011

2. Acute lymphoblastic leukaemia;Pui;Lancet,2008

3. Advances in acute lymphoblastic leukemia in adults;Ribera;Curr Opin Oncol,2011

4. Two groups of Philadelphia chromosome-positive childhood acute lymphoblastic leukemia classified by pretreatment multidrug sensitivity or resistance in in vitro testing;Hongo;Int J Hematol,2002

5. Acute lymphoblastic leukemia;Pui;N Engl J Med,2004

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytoplasmic Lipid Droplets Predict Worse Prognosis in Diffuse Large B-Cell Lymphoma;American Journal of Surgical Pathology;2024-07-09

2. m(6)A Modification of lncRNA NEAT1 Regulates Chronic Myelocytic Leukemia Progression via miR-766-5p/CDKN1A Axis;Frontiers in Oncology;2021-07-20

3. Targeting the Proteasome in Refractory Pediatric Leukemia Cells: Characterization of Effective Cytotoxicity of Carfilzomib;Targeted Oncology;2018-11-16

4. The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform;Drug Discovery Today;2015-12

5. Molecular insight into thiopurine resistance: transcriptomic signature in lymphoblastoid cell lines;Genome Medicine;2015-04-18